PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis

Min-Sik Lee1, Man-Hyung Jeong1, Hyun-Woo Lee2

  • 1Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea.

Nature Communications
|July 18, 2015
PubMed

Insights

Epidermal Growth Factor Receptor (EGFR) and PI3K/AKT signaling pathways promote cervical cancer progression by destabilizing phosphatase and tensin homologue (PTEN) through MKRN1 E3 ligase. This pathway correlates with reduced patient survival rates.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Post-translational modifications are known to suppress phosphatase and tensin homologue (PTEN) activity, but the precise mechanisms and physiological relevance remain largely undefined.
  • Understanding PTEN regulation is crucial in cervical cancer, where its dysregulation is implicated in tumorigenesis.

Purpose of the Study:

  • To elucidate the mechanism by which post-translational modifications lead to PTEN suppression in cervical cancer.
  • To investigate the role of Epidermal Growth Factor Receptor (EGFR) and PI3K/AKT signaling in PTEN destabilization.
  • To determine the clinical significance of these molecular events in cervical cancer patient survival.

Main Methods:

  • Utilized molecular biology techniques to investigate protein-protein interactions and degradation pathways.
  • Employed Western blotting and immunoprecipitation assays to assess protein levels and modifications.
  • Analyzed patient data to correlate molecular markers with clinical outcomes.

Main Results:

  • Demonstrated that Epidermal Growth Factor Receptor (EGFR) or oncogenic PI3K mutation-mediated AKT activation induces PTEN destabilization in cervical cancer.
  • Identified MKRN1 E3 ligase as essential for EGFR/PI3K/AKT-mediated ubiquitination and degradation of PTEN.
  • Showed that AKT-mediated phosphorylation stabilizes MKRN1, facilitating PTEN degradation.
  • Observed that high pAKT and MKRN1 expression in cervical cancer patients correlates with low PTEN protein levels and reduced 5-year survival rates.

Conclusions:

  • PI3K/AKT signaling pathways create a positive-feedback loop by suppressing PTEN function through MKRN1-mediated degradation.
  • The EGFR/AKT/MKRN1/PTEN axis represents a critical regulatory mechanism in cervical cancer.
  • Targeting this pathway holds potential for improving therapeutic strategies and patient outcomes in cervical cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K